Raphael Pharmaceutical, Inc. (RAPH)
1.51
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
Raphael Pharmaceutical Net Income (Quarterly) : -0.223M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.223M |
| March 31, 2026 | -0.229M |
| December 31, 2025 | -0.273M |
| September 30, 2025 | -0.255M |
| June 30, 2025 | -0.322M |
| March 31, 2025 | -0.429M |
| December 31, 2024 | -0.395M |
| September 30, 2024 | -0.326M |
| June 30, 2024 | -0.248M |
| March 31, 2024 | -0.55M |
| December 31, 2023 | 0.062M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.725M |
| June 30, 2023 | -0.417M |
| March 31, 2023 | -0.264M |
| December 31, 2022 | -1.103M |
| September 30, 2022 | -1.443M |
| June 30, 2022 | -0.627M |
| March 31, 2022 | -0.185M |
| September 30, 2021 | -0.416M |
| June 30, 2021 | -0.387M |
| March 31, 2021 | -0.255M |
| September 30, 2020 | -0.243M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| IM Cannabis Corp. | -3.168M |
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.223M |
| EPS Diluted (Quarterly) | -0.0111 |
| Enterprise Value | 30.51M |
| Earnings Yield | -3.26% |
| Normalized Earnings Yield | -3.252 |